IL1B and malignant colon neoplasm: In colon cancer, interleukin-1 (IL-1) and TAMs collaborate to activate NF-κB-dependent PDK1/AKT signalling in tumour cells, inactivating glycogen synthase kinase 3 beta (GSK3β), amplifying Wnt signalling, and fostering colon cancer cell proliferation [39].